CTCX logo

Carmell Therapeutics (CTCX) Depreciation And Amortization

Annual D&A

$124.80 K
-$117.80 K-48.56%

December 31, 2023


Summary


Performance

CTCX Depreciation And Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

Related metrics

Quarterly D&A

$42.90 K
-$15.40 K-26.42%

September 30, 2024


Summary


Performance

CTCX Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

Related metrics

TTM D&A

$215.70 K
+$97.00 K+81.72%

September 30, 2024


Summary


Performance

CTCX TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

Related metrics

CTCX Depreciation And Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-48.6%+179.3%+217.7%
3 y3 years-48.5%--
5 y5 years-48.5%--

CTCX Depreciation And Amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-48.6%at low-76.6%+179.3%-29.3%+217.7%
5 y5-year-48.6%at low-76.6%+179.3%-29.3%+217.7%
alltimeall time-48.6%at low-76.6%+179.3%-29.3%+217.7%

Carmell Therapeutics Depreciation And Amortization History

DateAnnualQuarterlyTTM
Sep 2024
-
$42.90 K(-26.4%)
$215.70 K(+81.7%)
Jun 2024
-
$58.30 K(+1.2%)
$118.70 K(-3.1%)
Mar 2024
-
$57.60 K(+1.2%)
$122.50 K(-1.8%)
Dec 2023
$124.80 K
$56.90 K(-205.2%)
$124.80 K(+83.8%)
Sep 2023
-
-$54.10 K(-187.1%)
$67.90 K(-77.7%)
DateAnnualQuarterlyTTM
Jun 2023
-
$62.10 K(+3.7%)
$305.00 K(+25.6%)
Mar 2023
-
$59.90 K(-67.3%)
$242.90 K(+32.7%)
Dec 2022
$242.60 K(+0.2%)
-
-
Sep 2022
-
$183.00 K
$183.00 K
Dec 2021
$242.10 K
-
-

FAQ

  • What is Carmell Therapeutics annual depreciation & amortization?
  • What is the all time high annual D&A for Carmell Therapeutics?
  • What is Carmell Therapeutics annual D&A year-on-year change?
  • What is Carmell Therapeutics quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Carmell Therapeutics?
  • What is Carmell Therapeutics quarterly D&A year-on-year change?
  • What is Carmell Therapeutics TTM depreciation & amortization?
  • What is the all time high TTM D&A for Carmell Therapeutics?
  • What is Carmell Therapeutics TTM D&A year-on-year change?

What is Carmell Therapeutics annual depreciation & amortization?

The current annual D&A of CTCX is $124.80 K

What is the all time high annual D&A for Carmell Therapeutics?

Carmell Therapeutics all-time high annual depreciation & amortization is $242.60 K

What is Carmell Therapeutics annual D&A year-on-year change?

Over the past year, CTCX annual depreciation & amortization has changed by -$117.80 K (-48.56%)

What is Carmell Therapeutics quarterly depreciation & amortization?

The current quarterly D&A of CTCX is $42.90 K

What is the all time high quarterly D&A for Carmell Therapeutics?

Carmell Therapeutics all-time high quarterly depreciation & amortization is $183.00 K

What is Carmell Therapeutics quarterly D&A year-on-year change?

Over the past year, CTCX quarterly depreciation & amortization has changed by +$97.00 K (+179.30%)

What is Carmell Therapeutics TTM depreciation & amortization?

The current TTM D&A of CTCX is $215.70 K

What is the all time high TTM D&A for Carmell Therapeutics?

Carmell Therapeutics all-time high TTM depreciation & amortization is $305.00 K

What is Carmell Therapeutics TTM D&A year-on-year change?

Over the past year, CTCX TTM depreciation & amortization has changed by +$147.80 K (+217.67%)